Anti-™EM50A monoclonal antibody

Pre-made anti-™EM50A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™EM50A/™EM50A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2107-Ab-1/ GM-Tg-hg-IP2107-Ab-2Anti-Human ™EM50A monoclonal antibodyHuman
GM-Tg-rg-IP2107-Ab-1/ GM-Tg-rg-IP2107-Ab-2Anti-Rat ™EM50A monoclonal antibodyRat
GM-Tg-mg-IP2107-Ab-1/ GM-Tg-mg-IP2107-Ab-2Anti-Mouse ™EM50A monoclonal antibodyMouse
GM-Tg-cynog-IP2107-Ab-1/ GM-Tg-cynog-IP2107-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM50A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2107-Ab-1/ GM-Tg-felg-IP2107-Ab-2Anti-Feline ™EM50A monoclonal antibodyFeline
GM-Tg-cang-IP2107-Ab-1/ GM-Tg-cang-IP2107-Ab-2Anti-Canine ™EM50A monoclonal antibodyCanine
GM-Tg-bovg-IP2107-Ab-1/ GM-Tg-bovg-IP2107-Ab-2Anti-Bovine ™EM50A monoclonal antibodyBovine
GM-Tg-equg-IP2107-Ab-1/ GM-Tg-equg-IP2107-Ab-2Anti-Equine ™EM50A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2107-Ab-1/ GM-Tg-hg-IP2107-Ab-2; GM-Tg-rg-IP2107-Ab-1/ GM-Tg-rg-IP2107-Ab-2;
GM-Tg-mg-IP2107-Ab-1/ GM-Tg-mg-IP2107-Ab-2; GM-Tg-cynog-IP2107-Ab-1/ GM-Tg-cynog-IP2107-Ab-2;
GM-Tg-felg-IP2107-Ab-1/ GM-Tg-felg-IP2107-Ab-2; GM-Tg-cang-IP2107-Ab-1/ GM-Tg-cang-IP2107-Ab-2;
GM-Tg-bovg-IP2107-Ab-1/ GM-Tg-bovg-IP2107-Ab-2; GM-Tg-equg-IP2107-Ab-1/ GM-Tg-equg-IP2107-Ab-2
Products NameAnti-™EM50A monoclonal antibody
Formatmab
Target Name™EM50A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™EM50A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2107-Ag-1Recombinant multi-species ™50A/ ™EM50A/ IFNRC protein


    Target information

    Target IDGM-IP2107
    Target Name™EM50A
    Gene ID23585,71817,298552,100424313,478181,101080983,504456,100071327
    Gene Symbol and Synonyms3200001F09Rik,CAM,IFNRC,RGD1305638,SMP1,™EM50A
    Uniprot AccessionO95807
    Uniprot Entry Name™50A_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183726
    Target ClassificationN/A

    The target: ™EM50A, gene name: ™EM50A, also named as IFNRC, SMP1. This gene is located in the RH gene locus, between the RHD and RHCE genes. The function of its protein product is unknown; however, its sequence has potential transmembrane domains suggesting that it may be an integral membrane protein. Its position between the RH genes suggests that polymorphisms in this gene may be tightly linked to RH haplotypes and may contribute to selective pressure for or against certain RH haplotypes. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.